ELGN-2112 for Intestinal Malabsorption in Preterm Infants

We are studying whether ELGN-2112 can help preterm infants with intestinal malabsorption achieve full feeding sooner and reduce the risk of serious complications. This trial compares the new treatment to a placebo to assess its safety and effectiveness.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Humulin R
Humulin R is an insulin medicine used to help control blood sugar in people with diabetes.
Importal Poeder In Sachets

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Insulin Human
Insulin Human is a substance that helps control blood sugar levels in people with diabetes.
Insulin Human (Rdna)
Insulin human (rDNA) is a substance that replaces or supplements insulin to lower blood sugar in people with diabetes.
Lactitol Monohydrate
Lactitol monohydrate is a substance that gently draws water into the intestines to soften stool and relieve constipation.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Actraphane 30
Actraphane 30 Flexpen
Actraphane 30 Innolet

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
University Hospital Salzburg
UK für Kinder- und Jugendheilkunde der PMU Salzburg - Division für Neonatalogie
Salzburg, Austria
Centre Hospitalier Intercommunal De Poissy Saint Germain
Neonatology
Chambourcy, France
Centre Hospitalier Universitaire De Nimes
Neonatology
Milhaud, France

Sponsor: Elgan Pharma Ltd.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.